Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 4/20 | 0.52 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | VNN1 | O95497 | 1/20 | 0.42 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4403341 | 0.90 | HPGD (0.51) | L3MBTL1TDP1HPGDCTBP2RAB9A | |
| SCHEMBL4940818 | 0.88 | L3MBTL1 (0.62) | L3MBTL1TDP1HPGDCTBP2RAB9A | |
| SCHEMBL7149195 | 0.84 | ALDH1A1 (0.52) | L3MBTL1TDP1HPGDRAB9AKMT2A | |
| SCHEMBL12770093 | 0.83 | L3MBTL1 (0.54) | L3MBTL1TDP1HPGDCTBP2RAB9A | |
| SCHEMBL1411319 | 0.83 | L3MBTL1 (0.62) | L3MBTL1TDP1HPGDCTBP2RAB9A | |
| SCHEMBL43309 | 0.82 | CA2 (0.58) | CTBP2RAB9ANPC1KMT2AMEN1 | |
| SCHEMBL17481548 | 0.82 | ALDH1A1 (0.59) | TDP1HPGDALDH1A1GAALMNA | |
| SCHEMBL5539303 | 0.82 | IAPP (0.40) | L3MBTL1TDP1HPGDALDH1A1GAA | |
| SCHEMBL8638768 | 0.81 | L3MBTL1 (0.51) | L3MBTL1TDP1HPGDCTBP2RAB9A | |
| SCHEMBL10258480 | 0.81 | HPGD (0.47) | L3MBTL1TDP1HPGDCTBP2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112521242-A | Preparation method of 4-n-propyl-p-xylene cyclic dimer | 东南大学 | 2021-03-19 | — | — | CN | claimed |
| CN-120136646-A | Method for synthesizing benzyl alkyl ketone compound by visible light catalysis | 中国科学院化学研究所 | 2025-06-13 | — | — | CN | disclosed |
| US-20250146144-A1 | Decarboxylation Coupling Electrocatalysis Method for Catalyzing Aromatic Trimethyl Ammonium Salt and A-Nickel Ketonate | CHANGZHOU INSTITUTE OF TECHNOLOGY (CN) | 2025-05-08 | — | — | US | disclosed |
| US-12281400-B1 | Decarboxylation coupling electrocatalysis method for catalyzing aromatic trimethyl ammonium salt and α-nickel ketonate | CHANGZHOU INSTITUTE OF TECHNOLOGY (CN) | 2025-04-22 | — | — | US | disclosed |
| CN-115786735-B | Lithium extractant and extraction method thereof | 重庆康普化学工业股份有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-114956932-B | Synthesis method of polysubstituted chiral tetrahydroquinoline compound | 东北大学秦皇岛分校 | 2023-11-10 | — | — | CN | disclosed |
| US-11780833-B2 | Emetine derivatives, prodrugs containing same, and methods of treating conditions using same | HOWARD UNIVERSITY (US) | 2023-10-10 | — | — | US | disclosed |
| CN-116324688-A | Method for manufacturing conductive member for touch panel, and conductive member for touch panel | 富士胶片株式会社 | 2023-06-23 | — | — | CN | disclosed |
| CN-115786735-A | Lithium extractant and extraction method thereof | 重庆康普化学工业股份有限公司 | 2023-03-14 | — | — | CN | disclosed |
| CN-114540848-A | Decarboxylation coupling electrocatalysis method for realizing catalysis of aromatic trimethyl ammonium salt and alpha-nickel keto acid | 常州工学院 | 2022-05-27 | — | — | CN | disclosed |
| EP-0939134-B1 | Processes for producing optically active 2-amino-1-phenylethanol derivatives | DAICEL CHEM (JP) | 2002-09-11 | — | — | EP | disclosed |
| US-6114582-A | DECYCLIZATION TO FORM A CHEMICAL INTERMEDIATE FOR PRODUCING AN ANTI-OBESITY AGENT AND ANTIDIABETIC AGENT | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2000-09-05 | — | — | US | disclosed |
| EP-0654534-B1 | Processes for producing optically active 2-amino-1-phenylethanol derivatives | DAICEL CHEM (JP) | 2000-03-01 | — | — | EP | disclosed |
| EP-0939134-A1 | Processes for producing optically active 2-amino-1-phenylethanol derivatives | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1999-09-01 | — | — | EP | disclosed |
| EP-0924194-A2 | Processes for producing optically active 2-amino-1-phenylethanol derivatives | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1999-06-23 | — | — | EP | disclosed |
| EP-0924193-A1 | Processes for producing optically active 2-amino-1-phenylethanol derivatives | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1999-06-23 | — | — | EP | disclosed |
| US-5811293-A | CULTURE PRODUCT AS CHEMICAL INTERMEDIATE FOR ANTI-OBESITY AGENT | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1998-09-22 | — | — | US | disclosed |
| US-5629200-A | MICROORGANISM | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1997-05-13 | — | — | US | disclosed |
| EP-0654534-A2 | Processes for producing optically active 2-amino-1-phenylethanol derivatives | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1995-05-24 | — | — | EP | disclosed |
| US-3992451-A | IN THE PRESENCE OF FREE RADICAL CATALYSTS, HYDROGEN CHLORIDE, AND CARBON MONOXIDE | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11780833-B2 | Emetine derivatives, prodrugs containing same, and methods of treating conditions using same | EML4, MCL1, ERAP2 | L3MBTL1 189/4885TDP1 1234/4885HPGD 1325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.